Nuvation Bio NUVB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $64.72M+1,999% | $26.16M+358% | $5.4M+642% | $3.6M+151% | $3.08M— | |
| Product Revenue | $18.5M+2,213% | $15.7M— | $7.7M— | $900K— | $800K— | |
| Research And Development Service Revenue | $700K-63.2% | —— | $1.9M+161% | $2.2M+53.3% | $1.9M— | |
| Royalty Revenue | $1.4M+600% | $300K— | $300K— | $200K— | $200K— | |
| Revenue by Geography | ||||||
| CN | $5.19M+78.8% | $972K-75.6% | $2.18M+3,260% | $3.35M+206% | $2.9M— | |
| JP | $652K+256% | $25.19M+1,361% | $3.21M+385% | $241K-29.1% | $183K— | |
| US | $77.39M— | $15.7M— | $7.72M— | $1.24M— | $0— | |
| Area Of Real Estate Property by Geography | ||||||
| CN | $1.8K+3.7% | $1.8K+3.7% | $1.74K+9.7% | $1.74K+9.7% | $1.74K+9.7% | |
| MA | $2.24K0.0% | $2.24K0.0% | $2.24K0.0% | $2.24K— | $2.24K— | |
| New York City | $7.9K0.0% | $7.9K0.0% | $7.9K0.0% | $7.9K0.0% | $7.9K0.0% | |
| San Francisco | $19.42K0.0% | $19.42K0.0% | $19.42K-22.8% | $19.42K-22.8% | $19.42K-22.8% | |
| Lessee Operating Lease Expiration Year by Geography | ||||||
| MA | 2K0.0% | —— | —— | —— | 2K+300% | |
| New York City | 2K0.0% | —— | —— | —— | 2K0.0% | |
| San Francisco | 2K0.0% | —— | —— | —— | 2K+0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nuvation Bio break its business down?
- Nuvation Bio (NUVB) reports revenue by product across 4 parts — License, Product Revenue, Research And Development Service Revenue and Royalty Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nuvation Bio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nuvation Bio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.